2 Day Seminar: FDA Scrutiny of Promotion and Advertising Practices (Philadelphia, PA, United States - May 17-18, 2018) - ResearchAndMarkets.com

The "FDA Scrutiny of Promotion and Advertising Practices" conference has been added to ResearchAndMarkets.com's offering.

In this seminar, you will learn how to navigate FDA's numerous legal options and how to interpret them based on basic legal principles.

Applying new guidance documents becomes a new test of the FDA's legal boundaries and enforcement options. The agency is now conducting clinical studies and applies the principles of cognitive psychology to aid in its determination of what a message really conveys. This academic discipline may or may not get to the root of what consumers take away as the message.

This conference will provide insight on how to manage your marketing activity and gauge what regulatory risks your business is willing to accept. You will learn how corporate management requires cooperation between marketing, regulatory affairs, legal counsel, manufacturing, engineering and finance departments.

Operating in a stovepipe environment will not work. You need to understand that a weak link in any department leaves the entire corporation vulnerable to FDA enforcement. Most importantly, you will understand the boundaries that FDA uses and how easy it is to cross them. With information from this course, you can step back and rationally evaluate your firm's regulatory profile for advertising and promotion practices.

Learning Objectives:

• Learn how FDA faces constitutional constraints on enforcement decisions
• Learn about intersecting federal requirements by the Department of Justice, the Federal Trade Commission, the Securities and Exchange Commission and the Consumer Product Safety Commission
• Learn how the FDA interprets advertising and promotion in principle and in fact
• Understand ways that a firm violates FDA requirements
• Evaluate advertising and promotional material based on interactive group hypotheticals
• See how sales and marketing departments play a central role, for better or worse
• Learn how the federal government holds executive management responsible for missteps in promotion and advertising practices

Agenda:

Day 1 Schedule

• Lecture 1: FDA legal authority
• Lecture 2: Promotion and Advertising: scope of labeling
• Lecture 3: Supreme Court / commercial free speech

Day 2 Schedule

• Lecture 1: Direct to consumer advertising vectors
• Lecture 2: False and misleading information
• Lecture 3: Off label use - practices and policy
• Lecture 4: Practice of medicine exemption

For more information about this conference visit https://www.researchandmarkets.com/research/8m486v/2_day_seminar?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180201006258/en/

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceuticals, Medical Devices

More From BioPortfolio on "2 Day Seminar: FDA Scrutiny of Promotion and Advertising Practices (Philadelphia, PA, United States - May 17-18, 2018) - ResearchAndMarkets.com"